Expression of the PEA3 group of ets-related transcription factors in human breast-cancer cells

International Journal of Cancer

Volumn 70, Issue 5, 1997, Pages 590-597

  Baert, Jean Luc ^a   Monté, Didier ^a,c   Musgrove, Elizabeth A ^b   Albagli, Olivier ^a,d   Sutherland, Robert L ^b   De Launoit, Yvan ^a  

^a INSTITUT PASTEUR DE LILLE   (France)

^b ST VINCENT S HOSPITAL   (Australia)

^c INSERM   (France)

^d LAVAL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; TRANSCRIPTION FACTOR;

ARTICLE; BREAST CANCER; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN CELL; PRIORITY JOURNAL;

ANIMALS; ANTIBODY SPECIFICITY; BREAST NEOPLASMS; DNA-BINDING PROTEINS; GENE EXPRESSION; HUMANS; MICE; NEOPLASM PROTEINS; RNA, MESSENGER; TRANSCRIPTION FACTORS; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 0030939489     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19970304)70:5<590::AID-IJC17>3.0.CO;2-H     Document Type: Article

References (21)

1. BROWN, T.A. and MCKNIGHT, S.L., Specificities of protein-protein and protein-DNA interaction of GABPα and two newly defined ets-related proteins. Genes Dev., 6, 2502-2512 (1992).
2. BUCKLEY, M.F., SWEENEY, K.J.E., HAMILTON, J.A., SINI, R.L., MANNING, D.L., NICHOLSON, R.I., DEFAZIO, A., WATTS, C.K.W., MUSGROVE, E.A. and SUTHERLAND, R.L., Expression and amplification of cyclin genes in human breast cancer. Oncogene, 8, 2127-2133 (1993).
3. CAMPBELL, D.H., DEFAZIO, A., SUTHERLAND, R.L. and DALY, R.J., Expression and tyrosine phosphorylation of EMSI in human breast-cancer cell lines. Int. J. Cancer, 68, 1-8 (1996).
4. CRÉPIEUX, P., COLL, J. and STÉHELIN, D., Ets family of proteins: weak modulators of gene expression in quest of transcriptional partners. Crit. Rev. Oncol., 5, 615-638 (1994).
5. DICKSON, R.B. and LIPPMAN, M.E., Growth factors in breast cancer. Endocrine Rev., 16, 559-589 (1995).
6. ESCOT, C., THEILLET, C., LIDEREAU, R., SPYRATOS, F., CHAMPEME, M.H., GEST, J. and CALLAHAN, R., Genetic alteration of the e-mye proto-oncogene (MYC) in human primary breast carcinomas. Proc. nat. Acad. Sci. (Wash.), 83, 4834-4838 (1986).
7. HIGASHINO, F., YOSHIDA, K., KAMIO, K. and FUJINAGA, K., Isolation of a cDNA encoding the adenovirus-E1 A-enhancer-binding protein: a new human member of the ets oncosene family. Nucleic Acids Res., 21, 547-553 (1993).
8. HIGASHINO, F., YOSHIDA, K., NOUMI, T., SEIKI, M. and FUJINAGA, K., Ets-related protein E1A-F can activate three different matrix metalloproteinase gene promoters. Oncogene, 10, 1461-1463 (1995).
9. JEON, I.-S., DAVIS, J.N., BRAUN, B.S., SUBLETT, J.E., ROUSSEL, M.F., DENNY, C.T. and SHAPIRO, D.N., A variant Ewing's-sarcoma translocation (7;22) fuses the EWS gene to the ETS gene ETVI. Oncogene. 10, 1229-1234 (1995).
10. KAYA, M., YOSHIDA, K., HIGASHINO, F., MITAKA, T., ISHII, S. and FUJINAGA, K., A single ets-related transcription factor, E1AF, confers invasive phenotype on human cancer cells. Oncogene, 12, 221-227 (1996).
11. KOZAK, M., Structural features in eukaryotic mRNAs that modulate the initiation of translation. J. biol. Chem., 266, 19867-19870 (1991).
12. MANNI, A., SANTEN, R.J. and HARVEY, H.A., Endocrine treatment of breast cancer: update 1993. Endocr. Rev. Monogr., 1, 46-48 (1993).
13. MONTÉ, D., BAERT, J.L., DEFOSSEZ, P.A., DE LAUNOIT, Y. and STÉHELIN, D., Molecular cloning and characterization of human ERM, a new member of the ETS family closely related to mouse PEA3 and ER81 transcription factors. Oncogene, 9, 1397-1406 (1994).
14. MONTÉ, D., COUTTE, L., BAERT, J.L., ANGELI, I., STÉHELIN, D. and DE LAUNOIT, Y., Molecular characterization of the Ets-related human transcription factor ER81. Oncogene, 11, 771-779 (1995).
15. NAKAE, K., NAKAJIMA, K., INAZAWA, J., KITAOKA, T. and HIRANO, T., ERM, a PEA3 sub-family of Ets transcription factors, can cooperate with c-Jun. J. biol. Chem., 270, 23795-23800 (1995).
16. ROMANO-SPICA, V., SUZUKI, H., GEORGIOU, P., CHEN, S.-L., ASCIONE, R., PAPAS, T.S. and BHAT, N.K., Expression of ets family senes in hematopoietic cells. Int. J. Oncol., 4, 521-531 (1994).
17. SCOTT, G.K., DANIEL, J.C., XIONG, X., MAKI, R.A., KABAT, D. and BENZ, C.C., Binding of an ETS-related protein within the DNase-I hypersensitive site of the HER2/neu promoter in human breast-cancer cells. J. biol. Chem., 269, 19848-19858 (1994).
18. SLAMON, D.J., G.M., C., WONG, S.G., LEVIN, W.J., ULLRICH, A. and MCGUIRE, W.L., Human breast cancer: correlation of relapse and survival with amplification of HER-2/nen oncogene. Science, 235, 177-182 (1987).
19. TRIMBLE, M.S., XIN, J.H., GUY, C.T., MULLER, W.J. and HASSELL, J.A., PEA3 is over-expressed in mouse metastatic mammary adenocarcinomas. Oncogene, 8, 3037-3042 (1993).
20. WASYLYK, B., WASYLYK, C., FLORES, P., BÈGUE, A., LEPRINCE, D. and STÉHELIN, B., The c-ets proto-oncogenes encode transcription factors that cooperate with c-Fos and c-Jun for transcriptional activation. Nature (Lond.), 346, 191-193 (1990).0
21. XIN, J.H., COWIE, A., LACHANCE, P. and HASSELL, J.A., Molecular cloning and characterization of PEA3. a new member of the ets oncoaene family that is differentially expressed in mouse embryonic cells. Genes Dev., 6, 481-496 (1992).